|
1
|
Siegel R, Ma JM, Zou ZH and Jemal A:
Cancer Statistics, 2014. CA Cancer J Clin. 64:9–29. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bokhman JV: Two pathogenetic types of
endometrial carcinoma. Gynecol Oncol. 15:10–17. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Liu FS: Molecular carcinogenesis of
endometrial cancer. Taiwan J Obstet Gynecol. 46:26–32. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Matias-Guiu X and Prat J: Molecular
pathology of endometrial carcinoma. Histopathology. 62:111–123.
2013. View Article : Google Scholar
|
|
5
|
Mercer TR, Dinger ME and Mattick JS: Long
non-coding RNAs: insights into functions. Nat Rev Genet.
10:155–159. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ponting CP, Oliver PL and Reik W:
Evolution and functions of long noncoding RNAs. Cell. 136:629–641.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang F, Li X, Xie X, Zhao L and Chen W:
UCA1, a non-protein-coding RNA up-regulated in bladder carcinoma
and embryo, influencing cell growth and promoting invasion. FEBS
Lett. 582:1919–1927. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yang C, Li X, Wang Y, Zhao L and Chen W:
Long non-coding RNA UCA1 regulated cell cycle distribution via CREB
through PI3-K dependent pathway in bladder carcinoma cells. Gene.
496:8–16. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang Y, Chen W, Yang C, et al: Long
non-coding RNA UCA1a (CUDR) promotes proliferation and
tumorigenesis of bladder cancer. Int J Oncol. 41:276–284.
2012.PubMed/NCBI
|
|
10
|
Li Z, Li X, Wu S, Xue M and Chen W: Long
non-coding RNA UCA1 promotes glycolysis by upregulating hexokinase
2 through the mTOR-STAT3/microRNA143 pathway. Cancer Sci.
105:951–955. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wu W, Bhagat TD, Yang X, et al:
Hypomethylation of noncoding DNA regions and overexpression of the
long noncoding RNA, AFAP1-AS1, in Barrett’s esophagus and
esophageal adenocarcinoma. Gastroenterology. 144:956–966. e42013.
View Article : Google Scholar
|
|
12
|
Weber DG, Johnen G, Casjens S, et al:
Evaluation of long noncoding RNA MALAT1 as a candidate blood-based
biomarker for the diagnosis of non-small cell lung cancer. BMC Res
Notes. 6:5182013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhao Y, Yang Y, Trovik J, et al: A novel
wnt regulatory axis in endometrioid endometrial cancer. Cancer Res.
74:5103–5117. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bansal N, Yendluri V and Wenham RM: The
molecular biology of endometrial cancers and the implications for
pathogenesis, classification, and targeted therapies. Cancer
Control. 16:8–13. 2009.
|
|
15
|
Yeramian A, Moreno-Bueno G, Dolcet X, et
al: Endometrial carcinoma: molecular alterations involved in tumor
development and progression. Oncogene. 32:403–413. 2013. View Article : Google Scholar
|
|
16
|
Getz G, Gabriel SB, Cibulskis K, et al:
Integrated genomic characterization of endometrial carcinoma.
Nature. 497:67–73. 2013. View Article : Google Scholar
|
|
17
|
Devor EJ, Hovey AM, Goodheart MJ,
Ramachandran S and Leslie KK: microRNA expression profiling of
endometrial endometrioid adenocarcinomas and serous adenocarcinomas
reveals profiles containing shared, unique and differentiating
groups of microRNAs. Oncol Rep. 26:995–1002. 2011.PubMed/NCBI
|
|
18
|
Hiroki E, Akahira J, Suzuki F, et al:
Changes in microRNA expression levels correlate with
clinicopathological features and prognoses in endometrial serous
adenocarcinomas. Cancer Sci. 101:241–249. 2010. View Article : Google Scholar
|
|
19
|
Joh RI, Palmieri CM, Hill IT and Motamedi
M: Regulation of histone methylation by noncoding RNAs. Biochim
Biophys Acta. 1839:1385–1394. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bonasio R and Shiekhattar R: Regulation of
transcription by long noncoding RNAs. Annu Rev Genet. 48:433–455.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kornfeld JW and Brüning JC: Regulation of
metabolism by long, non-coding RNAs. Front Genet. 5:572014.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Schonrock N, Harvey RP and Mattick JS:
Long noncoding RNAs in cardiac development and pathophysiology.
Circ Res. 111:1349–1362. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yang F, Zhang L, Huo XS, et al: Long
noncoding RNA high expression in hepatocellular carcinoma
facilitates tumor growth through enhancer of zeste homolog 2 in
humans. Hepatology. 54:1679–1689. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xu D, Yang F, Yuan JH, et al: Long
noncoding RNAs associated with liver regeneration 1 accelerates
hepatocyte proliferation during liver regeneration by activating
Wnt/β-catenin signaling. Hepatology. 58:739–751. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yang F, Huo XS, Yuan SX, et al: Repression
of the long noncoding RNA-LET by histone deacetylase 3 contributes
to hypoxia-mediated metastasis. Mol Cell. 49:1083–1096. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ito K, Utsunomiya H, Yaegashi N and Sasano
H: Biological roles of estrogen and progesterone in human
endometrial carcinoma - new developments in potential endocrine
therapy for endometrial cancer. Endocr J. 54:667–679. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Berstein LM, Imyanitov EN, Suspitsin EN,
et al: CYP19 gene polymorphism in endometrial cancer patients. J
Cancer Res Clin Oncol. 127:135–138. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Rizner TL, Smuc T, Rupreht R, Sinkovec J
and Penning TM: AKR1C1 and AKR1C3 may determine progesterone and
estrogen ratios in endometrial cancer. Mol Cell Endocrinol.
248:126–135. 2006. View Article : Google Scholar
|
|
29
|
Roger S, Potier M, Vandier C, Besson P and
Le Guennec JY: Voltage-gated sodium channels: new targets in cancer
therapy? Curr Pharm Des. 12:3681–3695. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Fraser SP, Ozerlat-Gunduz I, Brackenbury
WJ, et al: Regulation of voltage-gated sodium channel expression in
cancer: hormones, growth factors and auto-regulation. Philos Trans
R Soc Lond B Biol Sci. 369:201301052014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Brackenbury WJ: Voltage-gated sodium
channels and metastatic disease. Channels. 6:352–361. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhang Y, Hu X, Wang HK, et al:
Single-nucleotide polymorphisms of the PRKCG gene and osteosarcoma
susceptibility. Tumour Biol. 35:12671–12677. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kanetsky PA, Mitra N, Vardhanabhuti S, et
al: Common variation in KITLG and at 5q31.3 predisposes to
testicular germ cell cancer. Nat Genet. 41:811–815. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Cicek MS, Liu X, Casey G and Witte JS:
Role of androgen metabolism genes CYP1B1, PSA/KLK3, and CYP11alpha
in prostate cancer risk and aggressiveness. Cancer Epidemiol
Biomarkers Prev. 14:2173–2177. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kouznetsova A, Novak I, Jessberger R and
Hoog C: SYCP2 and SYCP3 are required for cohesin core integrity at
diplotene but not for centromere cohesion at the first meiotic
division. J Cell Sci. 118:2271–2278. 2005. View Article : Google Scholar : PubMed/NCBI
|
